AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod
AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod zbecker Fri, 04/26/2024 - 11:33
AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod zbecker Fri, 04/26/2024 - 11:33
Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’ aliu Fri, 04/26/2024 - 11:05
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose kdunleavy Fri, 04/26/2024 - 10:21
GSK pulls Pfizer and BioNTech into yet another COVID-19 vaccine patent lawsuit fkansteiner Fri, 04/26/2024 - 10:07
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again kdunleavy Fri, 04/26/2024 - 07:42
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB zbecker Thu, 04/25/2024 - 22:58
Fierce Pharma Asia—Novartis reworks China ties; Neurocrine-Takeda med passes depression test; Enhertu nears key readout aliu Thu, 04/25/2024 - 20:25